logo
Select company
Select metric
$ 0Net Cash Flow - Issuance (Repayment) of Debt Securities
VS
Market
36
Sector
24
Industry
19
History
20
$ 2.05Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Net Cash Flow - Issuance (Repayment) of Debt Securities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - CF - Debt Historical data
DateNet Cash Flow - Issuance (Repayment) of Debt Securities
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
6/30/2024$ -2.94M
12/31/2023$ -3.22M
6/30/2023$ -897.5K
12/31/2022$ -1.17M
6/30/2022$ -1.06M
12/31/2021$ -865K
6/30/2021$ -18.88M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) CF - Debt stands at $ 19.89M.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average CF - Debt has been $ -831.77K.
  • The median CF - Debt for MEREO BIOPHARMA GROUP PLC during this period was $ -897.5K
  • MEREO BIOPHARMA GROUP PLC reached its highest CF - Debt over the past 5 years at $ 19.89M.
  • The lowest CF - Debt recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe $ -18.88M

MEREO BIOPHARMA GROUP PLC's CF - Debt vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Debt Benchmarks
CompanyCF - Debt
CRDF : CARDIFF ONCOLOGY INC $ 0ABEO : ABEONA THERAPEUTICS INC $ 0HUMA : HUMACYTE INC $ -2.75MAVTX : AVALO THERAPEUTICS INC $ 0COYA : COYA THERAPEUTICS INC $ 0ABVC : ABVC BIOPHARMA INC $ 283.52KFDMT : 4D MOLECULAR THERAPEUTICS INC $ 0VTGN : VISTAGEN THERAPEUTICS INC $ 930KERNA : ERNEXA THERAPEUTICS INC $ 6.14MANNX : ANNEXON INC $ -515K

Similar metrics to CF - Debt:

Definition of Net Cash Flow - Issuance (Repayment) of Debt Securities

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.

MREO - Net Cash Flow - Issuance (Repayment) of Debt Securities, Last 5 years

$ -18.88M

Minimum

Jun 30, 2021

$ 19.89M

Maximum

Dec 31, 2020

$ -831.77K

Average

$ -897.5K

Median

CF - Debt Benchmark Analysis

 The chart above depicts the distribution of CF - Debt for companies in the Total Stock Market. The average CF - Debt of the companies is $ -1.66M with a standard deviation of $ 24.14M.
The following table provides additional summary stats:
CF - Debt in the Market:
filtered constituents2.85K
min$ -84.35M
max$ 83.81M
average$ -1.66M
median$ 0
std$ 24.14M